OSLM
Outcome Studies
in Laboratory Medicine
guest
👤
Learn more about this platform
c
Categories
p
Projects
Highlighted
Trial protocol
Study Design
RCT
Cluster RCT
Observational
Model
Meta-analysis
Review
Guideline
Outcomes
Change patient management
Clinical outcomes
Economics
Operational efficiencies
Patient-centeredness
Safety
Guide Policy Making
Other
Uncategorized
Antibiotic Guidance
ACT Guided Heparinization
Cancer
COVID-19
Cardiovascular Disease
Diabetes
HIV POCT
Inflammatory Bowel Disease
Liver Disease
Kidney Disease
Newborn Screening
MALDI-TOF MS For Microorganism Identification
Preeclampsia
Therapeutic drug monitoring
Pharmacogenetic and Pharmacogenomics
Viscoelastic Testing
Please contact us for any suggestions
Zhen Zhao
Smeralda Skenderaj
Search
Search
Categories:
Trial protocol
6 Publications
found
The Appropriately Designed TDM Clinical Trial: Endpoints, Pitfalls, and Perspectives.
b
Therapeutic drug monitoring
February 1, 2023
p
Therapeutic drug monitoring
c
Trial protocol
Proactive infliximab optimisation using a pharmacokinetic dashboard versus standard of care in patients with Crohn’s disease: study protocol for a randomised, controlled, multicentre, open-label study (the OPTIMIZE trial).
b
BMJ open
April 1, 2022
p
Therapeutic drug monitoring
c
Trial protocol
Prospective randomised controlled trial of adults with perianal fistulising Crohn’s disease and optimised therapeutic infliximab levels: PROACTIVE trial study protocol.
b
BMJ open
July 1, 2021
p
Therapeutic drug monitoring
c
Trial protocol
The effect of therapeutic drug monitoring of beta-lactam and fluoroquinolones on clinical outcome in critically ill patients: the DOLPHIN trial protocol of a multi-centre randomised controlled trial.
b
BMC infectious diseases
January 17, 2020
p
Therapeutic drug monitoring
c
Change patient management
Clinical outcomes
Economics
Trial protocol
Therapeutic drug monitoring of infliximab compared to standard clinical treatment with infliximab: study protocol for a randomised, controlled, open, parallel-group, phase IV study (the NOR-DRUM study).
b
Trials
January 6, 2020
p
Therapeutic drug monitoring
c
Trial protocol
Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trial.
b
Trials
June 6, 2019
p
Therapeutic drug monitoring
c
Change patient management
Clinical outcomes
Trial protocol